US Patent Issued to Novartis, Immutep on March 18 for "Antibody molecules to LAG-3 and uses thereof" (American, French Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,535, issued on March 18, was assigned to Novartis AG (Basel, Switzerland) and Immutep S.A.S. (Orsay, France).

"Antibody molecules to LAG-3 and uses thereof" was invented by Frederic Triebel (Versailles, France), Chrystelle Brignone (Chatenay-Malabry, France), Walter A. Blattler (Brookline, Mass.), Jennifer Marie Mataraza (Cambridge, Mass.), Catherine Anne Sabatos-Peyton (Cambridge, Mass.), Hwai Wen Chang (San Marcos, Calif.) and Gerhard Johann Frey (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antibody molecules that specifically bind to LAG-3 and bispecific antibody molecules with a first binding specificity for LAG-3 and a second bind...